Telniz Trio 6.25 Tablet is chiefly prescribed for the management of hypertension or high blood pressure, a condition that can lead to severe cardiovascular complications. This medicine belongs to the class of antihypertensives.
Telniz Trio 6.25 Tablet is indicated for:
• Management of high blood pressure or hypertension
• Reducing the risk of cardiovascular events, including heart attacks
• Lowering the incidence of stroke
• Facilitating the excretion of excess fluid and electrolytes
• Reducing the workload on the heart and maintaining stable blood pressure
• Take the tablet whole with a glass of water.
• Do not crush, chew, or break the tablet.
• Take the medicine at the same time each day for maximum effectiveness.
• Do not exceed the prescribed dosage or discontinue the medication without consulting your doctor.
Telniz Trio 6.25 Tablet is taken orally.
Common side effects of Telniz Trio 6.25 Tablet may include:
• Dizziness
• Headache
• Fatigue
• Peripheral oedema
• Palpitations
Telniz Trio 6.25 Tablet comprises three active components:
• Cilnidipine (10 mg): As a long-lasting calcium channel blocker, cilnidipine inhibits calcium entry into vascular smooth muscle cells. This results in relaxation and dilation of blood vessels, reducing peripheral vascular resistance and lowering blood pressure.
• Telmisartan (40 mg): An angiotensin II receptor blocker, telmisartan prevents the action of angiotensin II, a vasoconstrictive hormone. Consequently, blood vessels relax and widen, facilitating blood flow and reducing blood pressure.
• Chlorthalidone (6.25 mg): This thiazide-like diuretic promotes the excretion of excess water and electrolytes through urine, thereby decreasing fluid volume in the blood vessels. This action helps in reducing the cardiac load and maintaining lower blood pressure over time.
Telniz Trio 6.25 Tablet is contraindicated during pregnancy due to potential harm to the foetus. Consult your doctor if you are pregnant or planning to conceive.
Exercise caution when using this medicine if you are breastfeeding.
Avoid alcohol consumption as it may enhance the hypotensive effect of this medicine, leading to dizziness or fainting.
Use with caution if you have liver impairment, as this medication may alter liver function. Consult your doctor prior to use.
If you have a history of kidney issues, consult your doctor before taking this medicine, as it may exacerbate renal dysfunction.
This medication may induce dizziness or fatigue, which can impair your ability to drive or operate machinery.
Do not take Telniz Trio 6.25 Tablet if you have an allergy to any of its components. Discuss alternatives with your doctor.
This medicine is not indicated for use in individuals under 18 years of age.
Older individuals should use this medicine under medical supervision due to increased sensitivity to side effects. Caution is advised for patients over 70 years.
Drug-Drug Interactions
• Antihypertensives: Concurrent use with other antihypertensives may potentiate hypotensive effects.
• Antidiabetics: May affect glucose control, necessitating close monitoring of blood sugar levels.
• Non-Steroidal Anti-inflammatory Drugs (NSAIDs): May impair the efficacy of Telniz Trio 6.25 Tablet in lowering blood pressure.
• Cardiac Glycosides: May increase the risk of cardiac side effects when used concomitantly.
Drug-Disease Interactions
• Diabetes: The diuretic component may impact blood sugar control, necessitating adjustments in diabetes management.
Daily Dosage
• Telniz Trio 6.25 Tablet should be taken as prescribed by your doctor. The dosage may change based on individual factors such as the severity of the condition and response to treatment. It is essential to follow the prescribed dosage and not exceed it without consulting your doctor.
Missed Dose
• If you miss a dose, take it as soon as you remember. If it is almost time for the next dose, skip the missed dose. Do not double the dose to compensate for the missed dose.
Overdose
• Overdose symptoms may include dizziness, fatigue, or nausea. Seek immediate medical attention in such cases.
• Store at room temperature, below 30°C.
• Keep in a dry place, protected from moisture and heat.
• Keep out of reach of children.
• Ensure the tablet is used before the expiry date.
• Limit salt intake to assist in managing hypertension effectively.
• Engage in regular physical activity to support cardiovascular health and enhance the efficacy of Telniz Trio 6.25 Tablet.
.avif)
%20(1).png)
.webp)